What's Going on With Gilead Sciences Stock Monday? - Gilead Sciences (NASDAQ:GILD)

HSBC upgrades Gilead Sciences (GILD) to Buy, raising its price target to $155 on strong long-acting HIV & oncology potential.

Raccontata dabenzinga.com